Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Recipharm appoints new Key Account Director for Europe Recipharm appoints new Key Account Director for Europe Anke Mollowitz is responsible for coordinating customer management and commercial aspects Remi Palmantier becomes Chief Scientific Officer at Genticel Remi Palmantier becomes Chief Scientific Officer at Genticel Will accelerate the discovery, development and integration of specific immunotherapies Chief Medical Officer Birgitte Volck to leave Sobi Chief Medical Officer Birgitte Volck to leave Sobi To join GlaxoSmithKline as Head of R&D Rare Diseases Ergomed makes changes to Board of Directors Ergomed makes changes to Board of Directors Neil Clark becomes CEO of PrimeVigilance, while Stephen Stamp is appointed as Chief Financial Officer of Ergomed Crown Bioscience hires Global Scientific Director for Translational Oncology Crown Bioscience hires Global Scientific Director for Translational Oncology Eric Murphy has focused on translational and drug discovery research for more than two decades ClinTec International expands executive leadership team ClinTec International expands executive leadership team Hires Dr Harley Simon as Chief Medical Officer & Executive Vice President Client Relations West appoints VP, Corporate Development, Strategy and Investor Relations West appoints VP, Corporate Development, Strategy and Investor Relations Quintin Lai joins the US firm from Sigma Aldrich Chalcroft announces new structure following significant growth Chalcroft announces new structure following significant growth Gives new roles to management and makes some promotions Frank Mathias to become CEO of Rentschler Biotechnologie Frank Mathias to become CEO of Rentschler Biotechnologie Nikolaus Rentschler joins supervisory board to concentrate on further expansion of the Rentschler Group Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France Yves Buelens, who has been plant manager since 2014, gains a promotion Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer He beings extensive experience to the newly created role HUYA Bioscience International expands senior management team HUYA Bioscience International expands senior management team Recruits Dmitri Kharkevitch as Vice President for Clinical Development Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer Brings two decades of experience in quality, manufacturing, product safety and regulatory affairs to the firm Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing Will lead business activity concerning SMARTag bioconjugation technology Lonza announces change to Executive Committee Lonza announces change to Executive Committee Sven Abend, Chief Strategy Officer and member of the Executive Committee, takes responsibility for Specialty Ingredients from Beat In-Albon Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development New role strengthens Immune's ability to advance portfolio through strategic partnering Joseph P. Hagan becomes Chief Operating Officer at Regulus Joseph P. Hagan becomes Chief Operating Officer at Regulus He brings nearly 15 years of experience to the La Jolla, CA, US-based firm Belgian biotech Promethera makes two senior appointments Belgian biotech Promethera makes two senior appointments Dr Jürgen Beck is hired as VP Clinical and Medical Affairs, with Patrick Stragier as VP Operations Schott researcher receives Turner Award Schott researcher receives Turner Award Professor Volker Rupertus is honoured for his involvement in the International Commission on Glass Abzena hires Dr Campbell Bunce to new role of SVP Scientific Operations Abzena hires Dr Campbell Bunce to new role of SVP Scientific Operations Adds further immunology expertise to the Executive Management Team Auspherix appoints Dr Neil Miller as Chief Scientific Officer Auspherix appoints Dr Neil Miller as Chief Scientific Officer He spent two decades in the pharmaceutical industry at GlaxoSmithKline Catherine Turkel joins OticPharma as Chief Development Officer Catherine Turkel joins OticPharma as Chief Development Officer Will lead the firm's preclinical, clinical, regulatory and CMC functions in the US Dr Robert Zeldin takes over as Chief Medical Officer at Ablynx Dr Robert Zeldin takes over as Chief Medical Officer at Ablynx He will lead the company's global clinical development, regulatory and medical affairs activities Innophos appoints Kim Ann Mink as Chief Executive Innophos appoints Kim Ann Mink as Chief Executive Current CEO Randy Gress plans to retire
  • Previous
  • 1
  • …
  • 66
  • 67
  • 68
  • 69 (current)
  • 70
  • 71
  • 72
  • …
  • 142
  • Next

Trending Articles

  1. Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the appointment of Itta MacNevin as Chief Business Officer (CBO). The appointment marks a significant step in Quibim’s strategy to scale its commercial operations, deepen partnerships across life sciences, and accelerate adoption of its AI-powered imaging solutions globally
  2. New leadership at DWK Life Sciences: Michael Werth succeeds Armin Reiche After serving as CEO for 25 years, Armin Reiche hands operational responsibility to Michael Werth and joins the Advisory Board
  3. Resyca announces the appointment of Deborah Jones as CEO Dr Jones brings more than 20 years of executive leadership experience driving commercial growth in life sciences technology companies
  4. MasterControl appoints David Edwards as CEO to drive next phase of growth Former CEO Jon Beckstrand Appointed Chairman of the Board; Prior Chair and Salt Lake City Business Pioneer Richard Beckstrand Transitions to Board Member
  5. Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth ProBioGen announced the appointment of Dr. Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.